文献速递妇科

高强度聚焦超声治疗子宫腺肌病有效吗?系统评价与Meta分析

Is High-intensity Focused Ultrasound Effective for the Treatment of Adenomyosis? A Systematic Review and Meta-analysis.
PubMed 文献 · J Minim Invasive Gynecol · 2019-08-01

本系统评价与Meta分析检索PubMed/MEDLINE和Cochrane数据库,纳入近10年英文发表的HIFU治疗子宫腺肌病研究。Meta分析显示HIFU后12个月子宫体积缩小效应量大(SMD=0.85),痛经在3个月(SMD=1.83)和12个月(SMD=2.37)显著减轻,生活质量在6个月(SMD=3.0)和12个月(SMD=2.75)显著改善;55.9%患者报告不良反应。作者认为HIFU对子宫腺肌病相关症状有潜在获益,但证据基于较少且非均一的研究。

要点

  • HIFU后12个月子宫体积缩小效应量为SMD=0.85。
  • 痛经在3个月(SMD=1.83)和12个月(SMD=2.37)显著减轻。
  • 生活质量在6个月(SMD=3.0)和12个月(SMD=2.75)显著改善,55.9%患者报告不良反应。

核心结论

  • 本综述提示HIFU对子宫腺肌病相关症状有潜在获益,但Meta分析结果基于较少且非均一的研究,未能全面均衡地考虑每一特定症状/参数。
  • 目前尚无比较HIFU与其他保守治疗方案的对照随机临床试验,关于生育和妊娠结局的数据尚不充分。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed/MEDLINE和Cochrane数据库,纳入近10年英文发表的评估HIFU治疗子宫腺肌病效果的所有可用研究,遵循PRISMA指南,对同质研究数据进行Meta分析。

主要发现

  • HIFU治疗子宫腺肌病后12个月子宫体积缩小效应量大(SMD=0.85)。
  • 痛经在3个月(SMD=1.83)和12个月(SMD=2.37)显著减轻。
  • 生活质量在6个月(SMD=3.0)和12个月(SMD=2.75)显著改善。
  • HIFU后55.9%患者报告不良反应。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • Meta分析结果基于较少且非均一的研究,未能全面均衡地考虑每一特定症状/参数。
  • 目前尚无比较HIFU与其他保守治疗方案的对照随机临床试验。
  • 关于生育和妊娠结局的数据尚不充分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To systematically review the literature regarding the efficacy of high-intensity focused ultrasound (HIFU) in reducing adenomyotic lesions, patients' pain and bleeding symptoms, and the impact on patients' quality of life. DATA SOURCE: A search was performed through PubMed/MEDLINE and Cochrane databases. METHODS OF STUDY SELECTION: All available studies published in the English language in the last 10 years that evaluated the effects of HIFU for adenomyosis. TABULATION, INTEGRATION, AND RESULTS: A systematic review was performed following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A meta-analysis was performed on data from homogeneous studies. Pooled results from the meta-analysis showed that after HIFU treatment for adenomyosis, a large effect was observed in reducing the uterine volume at 12 months (standard mean difference [SMD] = 0.85), a significant reduction in dysmenorrhea at 3 months (SMD = 1.83) and 12 months (SMD = 2.37), and a significant improvement in quality of life at 6 months (SMD = 3.0) and 12 months (SMD = 2.75). Adverse reactions after HIFU were reported in 55.9% of patients. CONCLUSION: This review suggests a potential benefit for HIFU in the treatment of adenomyosis-related symptoms; however, findings of the meta-analysis were based on fewer, nonuniform studies, which did not equally account for each specific symptom/parameter across the board. Results showed there appears to be a potential of HIFU in the treatment of adenomyosis-related symptoms. To date, there are no comparative and randomized clinical trials comparing the HIFU technique with other conservative treatment options. As yet, there are insufficient data regarding fertility and pregnancy outcomes.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Marques ALS, Andres MP, Kho RM, et al. Is High-intensity Focused Ultrasound Effective for the Treatment of Adenomyosis? A Systematic Review and Meta-analysis. J Minim Invasive Gynecol. 2019. PMID: 31377454. doi:10.1016/j.jmig.2019.07.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。